University of Wisconsin–Madison

Intermune PIPF – 016

December 2011 to June 2013

To confirm the effect of pirfenidine on reducing the decline in lung function observed in previous studies. Primary endpoint will be change in % FVC from Day 1 to Week 52.

This project led by: Keith Meyer, MD